» Articles » PMID: 36681663

Obesity Promotes Radioresistance Through SERPINE1-mediated Aggressiveness and DNA Repair of Triple-negative Breast Cancer

Overview
Journal Cell Death Dis
Date 2023 Jan 21
PMID 36681663
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a risk factor in various types of cancer, including breast cancer. The disturbance of adipose tissue in obesity highly correlates with cancer progression and resistance to standard treatments such as chemo- and radio-therapies. In this study, in a syngeneic mouse model of triple-negative breast cancer (TNBC), diet-induced obesity (DIO) not only promoted tumor growth, but also reduced tumor response to radiotherapy. Serpine1 (Pai-1) was elevated in the circulation of obese mice and was enriched within tumor microenvironment. In vitro co-culture of human white adipocytes-conditioned medium (hAd-CM) with TNBC cells potentiated the aggressive phenotypes and radioresistance of TNBC cells. Moreover, inhibition of both cancer cell autonomous and non-autonomous SERPINE1 by either genetic or pharmacological strategy markedly dampened the aggressive phenotypes and radioresistance of TNBC cells. Mechanistically, we uncovered a previously unrecognized role of SERPINE1 in DNA damage response. Ionizing radiation-induced DNA double-strand breaks (DSBs) increased the expression of SERPINE1 in cancer cells in an ATM/ATR-dependent manner, and promoted nuclear localization of SERPINE1 to facilitate DSB repair. By analyzing public clinical datasets, higher SERPINE1 expression in TNBC correlated with patients' BMI as well as poor outcomes. Elevated SERPINE1 expression and nuclear localization were also observed in radioresistant breast cancer cells. Collectively, we reveal a link between obesity and radioresistance in TNBC and identify SERPINE1 to be a crucial factor mediating obesity-associated tumor radioresistance.

Citing Articles

S1PR1 suppresses lung adenocarcinoma progression through p-STAT1/miR-30c-5 p/FOXA1 pathway.

Chai Y, Xiang H, Ma Y, Feng W, Jiang Z, Zhu Q J Exp Clin Cancer Res. 2024; 43(1):304.

PMID: 39551792 PMC: 11571582. DOI: 10.1186/s13046-024-03230-5.


Benzo[a]pyrene exposure prevents high fat diet-induced obesity in the 4T1 model of mammary carcinoma.

Gonzalez-Pons R, Bernard J Front Oncol. 2024; 14:1394039.

PMID: 39301545 PMC: 11410564. DOI: 10.3389/fonc.2024.1394039.


Obesity-Associated Breast Cancer: Analysis of Risk Factors and Current Clinical Evaluation.

Engin A Adv Exp Med Biol. 2024; 1460:767-819.

PMID: 39287872 DOI: 10.1007/978-3-031-63657-8_26.


Comparing long-term prognosis following different surgical methods in patients with early stage breast cancer and obesity: a retrospective cohort study in China.

Li L, Pang J, Yan Y, Zhang Q, Zheng S, Chen M BMJ Open. 2024; 14(8):e078816.

PMID: 39214662 PMC: 11367398. DOI: 10.1136/bmjopen-2023-078816.


Bibliometric analysis of phosphoglycerate kinase 1 expression in breast cancer and its distinct upregulation in triple-negative breast cancer.

Chen J, Li J, He R, Huang Z, Chen G, Zou W World J Clin Oncol. 2024; 15(7):867-894.

PMID: 39071464 PMC: 11271732. DOI: 10.5306/wjco.v15.i7.867.


References
1.
Bravata V, Cammarata F, Minafra L, Musso R, Pucci G, Spada M . Gene Expression Profiles Induced by High-dose Ionizing Radiation in MDA-MB-231 Triple-negative Breast Cancer Cell Line. Cancer Genomics Proteomics. 2019; 16(4):257-266. PMC: 6609258. DOI: 10.21873/cgp.20130. View

2.
Waller V, Pruschy M . Combined Radiochemotherapy: Metalloproteinases Revisited. Front Oncol. 2021; 11:676583. PMC: 8155607. DOI: 10.3389/fonc.2021.676583. View

3.
Ma L, Mao S, Taylor K, Kanjanabuch T, Guan Y, Zhang Y . Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes. 2004; 53(2):336-46. DOI: 10.2337/diabetes.53.2.336. View

4.
Pereira B, Chin S, Rueda O, Vollan H, Provenzano E, Bardwell H . The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016; 7:11479. PMC: 4866047. DOI: 10.1038/ncomms11479. View

5.
Renehan A, Zwahlen M, Egger M . Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer. 2015; 15(8):484-98. DOI: 10.1038/nrc3967. View